HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+3.78%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$274M
AUM Growth
+$274M
(-2.4%)
Cap. Flow
+$1.08M
Cap. Flow
% of AUM
0.39%
Top 10 Holdings %
Top 10 Hldgs %
29.37%
Holding
164
New
33
Increased
27
Reduced
41
Closed
27
Top Buys
| 1 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
$4.39M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
$4.25M |
| 3 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
$4.02M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$2.22M |
| 5 |
Salesforce
CRM
|
$2.19M |
Top Sells
| 1 |
SP
SP Plus Corporation
SP
|
$4.12M |
| 2 |
Orthofix Medical
OFIX
|
$2.44M |
| 3 |
Nuvalent
NUVL
|
$2.38M |
| 4 |
Immunocore
IMCR
|
$2.26M |
| 5 |
IDEAYA Biosciences
IDYA
|
$2.05M |
Sector Composition
| 1 | Healthcare | 43.71% |
| 2 | Technology | 17% |
| 3 | Consumer Discretionary | 6.54% |
| 4 | Energy | 4.11% |
| 5 | Consumer Staples | 3.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Invesco DB Commodity Index Tracking Fund
DBC
$1.27B
| $33.4M | 12.19% | 1,436,136 | – | – |
|
2
Insmed
INSM
$28.8B
| $8.49M | 3.1% | 126,780 | – | – |
|
3
Merus
MRUS
$4.98B
| $6.91M | 2.52% | 116,718 -4,962 | -4% | -$294K |
|
|
4
Salesforce
CRM
$245B
| $5.45M | 1.99% | 21,185 +8,506 | +67% | +$2.19M |
|
5
Axsome Therapeutics
AXSM
$6.05B
| $5.01M | 1.83% | 62,192 +13,665 | +28% | +$1.1M |
|
|
HCP
6
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $4.39M | 1.6% | +130,200 | New | +$4.39M |
|
|
HES
7
DELISTED
Hess
HES
| $4.26M | 1.56% | 28,900 | – | – |
|
|
CTLT
8
DELISTED
CATALENT, INC.
CTLT
| $4.25M | 1.55% | +75,600 | New | +$4.25M |
|
|
JNPR
9
DELISTED
Juniper Networks
JNPR
| $4.18M | 1.53% | 114,700 | – | – |
|
|
ANSS
10
DELISTED
Ansys
ANSS
| $4.12M | 1.5% | 12,800 | – | – |
|
11
Microsoft
MSFT
$3.77T
| $4.09M | 1.5% | 9,158 -3,100 | -25% | -$1.39M |
|
|
ETRN
12
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $4.02M | 1.47% | +310,000 | New | +$4.02M |
|
|
CERE
13
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $3.97M | 1.45% | 97,200 | – | – |
|
14
Albertsons Companies
ACI
$10.9B
| $3.73M | 1.36% | 188,753 | – | – |
|
|
AMED
15
DELISTED
Amedisys
AMED
| $3.6M | 1.32% | 39,250 | – | – |
|
16
Amazon
AMZN
$2.44T
| $3.48M | 1.27% | 17,993 -2,100 | -10% | -$406K |
|
17
Intuit
INTU
$186B
| $3.2M | 1.17% | 4,863 +1,900 | +64% | +$1.25M |
|
18
Apogee Therapeutics
APGE
$2.17B
| $3.11M | 1.13% | 78,942 -40,461 | -34% | -$1.59M |
|
19
Booking.com
BKNG
$181B
| $3M | 1.1% | 757 | – | – |
|
20
Maplebear
CART
$11.4B
| $2.99M | 1.09% | 92,988 +30,588 | +49% | +$983K |
|
21
argenx
ARGX
$43.6B
| $2.84M | 1.04% | 6,604 -141 | -2% | -$60.6K |
|
22
Xenon Pharmaceuticals
XENE
$2.98B
| $2.84M | 1.04% | 72,715 | – | – |
|
23
Arcellx
ACLX
$3.85B
| $2.82M | 1.03% | 51,040 -21,190 | -29% | -$1.17M |
|
24
Xoma
XOMA
$392M
| $2.82M | 1.03% | 118,899 | – | – |
|
25
Indivior
INDV
$3.03B
| $2.8M | 1.02% | 178,836 | – | – |
|